Clinical Trial Update: Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical study evaluating Adebrelimab combined with decitabine, albumin-bound paclitaxel, and gemcitabine as first-line therapy for metastatic pancr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Albumin-bound paclitaxel (nab-paclitaxel)
• Decitabine (Decitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Adebrelimab (SHR-1316), Decitabine | Phase 1, Phase 2 | Status: RECRUITING